Title: Further in vivo data demonstrating the efficacy of our novel compound OH14 in targeting triple negative breast cancer stem cells

Funder
Team Verrico

Principal Investigator

Project Details
Net value award figure for Cardiff University: £11,762.00
Start date: 01/03/2019
End date: 31/12/2020

Last updated on 2021-06-03 at 06:03